Evidence map›Paper›PMID 27232500›Full record

ArticlePloS one2016

Characterization of NF-κB Reporter U937 Cells and Their Application for the Detection of Inflammatory Immune-Complexes.

Csilla Kecse-Nagy, Zoltán Szittner, Krisztián Papp, Zoltán Hegyi, Paolo Rovero, Paola Migliorini, Veronika Lóránd, László Homolya, József Prechl

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.3field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 15 citations in OpenAlex.

  1. Analysis of BeyfortusCurrent issues in molecular biology · 2024
    Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 2 countries.

Csilla Kecse-NagyDepartment of Immunology, Eötvös Loránd University, H-1117, Pázmány Péter s. 1/C, Budapest, Hungary.
Zoltán SzittnerMTA-ELTE Immunology Research Group, H-1117, Pázmány Péter s. 1/C, Budapest, Hungary.
Krisztián PappMTA-ELTE Immunology Research Group, H-1117, Pázmány Péter s. 1/C, Budapest, Hungary.
Zoltán HegyiInstitute of Enzymology, Research Centre for Natural Sciences, Hungarian Academy of Sciences, H-1117 Budapest, Magyar tudósok körútja 2, Budapest, Hungary.
Paolo RoveroDepartment of NeuroFarBa, Section of Pharmaceutical Sciences and Nutraceutics, Laboratory of Peptide and Protein Chemistry and Biology, University of Florence, Via Ugo Schiff 6, 50019, Sesto Fiorentino, Italy.
Paola MiglioriniClinical Immunology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Veronika LórándDepartment of Rheumatology and Immunology, Clinic Center, PTE, Pécs, Hungary.
László HomolyaInstitute of Enzymology, Research Centre for Natural Sciences, Hungarian Academy of Sciences, H-1117 Budapest, Magyar tudósok körútja 2, Budapest, Hungary.
József PrechlMTA-ELTE Immunology Research Group, H-1117, Pázmány Péter s. 1/C, Budapest, Hungary.
Eötvös Loránd University · HUHUN-REN Research Centre for Natural Sciences · HUInstitute of Molecular Life Sciences · HUUniversity of Florence · ITUniversity of Pecs · HUUniversity of Pisa · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Our study tested the hypothesis that immunoglobulins differ in their ability to activate the nuclear factor-κB pathway mediated cellular responses. These responses are modulated by several properties of the immune complex, including the ratio of antibody isotypes binding to antigen. Immunoassays allow the measurement of antigen specific antibodies belonging to distinct immunoglobulin classes and subclasses but not the net biological effect of the combination of these antibodies. We set out to develop a biosensor that is suitable for the detection and characterization of antigen specific serum antibodies. We genetically modified the monocytoid U937 cell line carrying Fc receptors with a plasmid encoding NF-κB promoter-driven GFP. This clone, U937-NF-κB, was characterized with respect to FcR expression and response to solid-phase immunoglobulins. Human IgG3, IgG4 and IgG1 induced GFP production in a time- and dose-dependent manner, in this order of efficacy, while IgG2 triggered no activation at the concentrations tested. IgA elicited no response alone but showed significant synergism with IgG3 and IgG4. We confirmed the importance of activation via FcγRI by direct stimulation with monoclonal antibody and by competition assays. We used citrullinated peptides and serum from rheumatoid arthritis patients to generate immune complexes and to study the activation of U937-NF-κB, observing again a synergistic effect between IgG and IgA. Our results show that immunoglobulins have distinct pro-inflammatory potential, and that U937-NF-κB is suitable for the estimation of biological effects of immune-complexes, offering insight into monocyte activation and pathogenesis of antibody mediated diseases.

Indexed as

Antigen-Antibody ComplexFemaleGreen Fluorescent ProteinsHumansImmunoglobulin AImmunoglobulin GInflammationLipopolysaccharidesMaleNF-kappa BProtein TransportReceptors, IgGResponse ElementsU937 CellsAntigen-Antibody ComplexFCGR1A protein, humanGreen Fluorescent ProteinsImmunoglobulin AImmunoglobulin GLipopolysaccharidesNF-kappa BReceptors, IgG

Identifiers

PMID27232500
PMCPMC4883785
OpenAlexW2399768640

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.